Bone Regeneration System Articles & Analysis
7 news found
OSSIO’s contract with Vizient covers the entire OSSIOfiber Intelligent Bone Regeneration Technology portfolio currently commercialized and cleared by the U.S. ...
This is the third FDA clearance for the company’s OSSIOfiber® Intelligent Bone Regeneration Technology, which uses proprietary bio-integrative material to provide stability and secure bone fixation while leaving no permanent hardware behind. ...
Sam shares that “I am honored to have this opportunity to participate in bringing to market this exciting and rather unique bone regeneration platform technology, and to join a team that has developed this groundbreaking medical device. ...
Founded in 2014, NuShores is the licensee of UA Little Rock’s bone regeneration products, which have been developed primarily with DoD funding. ...
He will lead NuShores Generation 1 manufacturing of NuCress™ bone void filler scaffold products and serve as the Program Director and Principal Investigator on new and pending manufacturing projects to automate the company’s production systems. ...
Biomatlante, a world leader in synthetic bone regeneration technologies, is pleased to announce the obtention of the MDSAP* accreditation on the new ISO 13485:2016 Certificate. The Medical Device Single Audit Program (MDSAP) is an international program for assessing the quality management systems of medical device manufacturers who market their ...
UA Little Rock wrote about us: https://ualr.edu/news/2018/09/20/nushores-biosciences-receives-1-7-million-grant-to-study-bone-regeneration-technology ...